Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

247 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correlates of protection and determinants of SARS-CoV-2 breakthrough infections 1 year after third dose vaccination.
Martín Pérez C, Aguilar R, Jiménez A, Salmerón G, Canyelles M, Rubio R, Vidal M, Cuamba I, Barrios D, Díaz N, Santano R, Serra P, Santamaria P, Izquierdo L, Trilla A, Vilella A, Barroso S, Tortajada M, García-Basteiro AL, Moncunill G, Dobaño C. Martín Pérez C, et al. Among authors: trilla a. BMC Med. 2024 Mar 8;22(1):103. doi: 10.1186/s12916-024-03304-3. BMC Med. 2024. PMID: 38454385 Free PMC article.
Immunogenicity of a third dose with mRNA-vaccines in the ChAdOx1-S/BNT162b2 vaccination regimen against SARS-CoV-2 variants.
García-Pérez J, Borobia AM, Pérez-Olmeda M, Portolés A, Castaño L, Campins-Artí M, Bertrán MJ, Bermejo M, Arribas JR, López A, Ascaso-Del-Rio A, Arana-Arri E, Fuentes Camps I, Vilella A, Cascajero A, García-Morales MT, Castillo de la Osa M, Pérez Ingidua C, Lora D, Jiménez-Santana P, Pino-Rosa S, Gómez de la Cámara A, De La Torre-Tarazona E, Calonge E, Cruces R, Belda-Iniesta C, Alcamí J, Frías J, Carcas AJ, Díez-Fuertes F; CombiVacS Study Group. García-Pérez J, et al. iScience. 2024 Aug 14;27(9):110728. doi: 10.1016/j.isci.2024.110728. eCollection 2024 Sep 20. iScience. 2024. PMID: 39286494 Free PMC article.
Impact of the COVID-19 pandemic on the diagnosis and treatment of onco-hematologic patients: a discussion paper.
Bouza E, Martin M, Alés JE, Aragonés N, Barragán B, de la Cámara R, Del Pozo JL, García-Gutiérrez V, García-Sanz R, Gracia D, Guillem V, Jiménez-Yuste V, Martin-Delgado MC, Martínez J, López R, Rodríguez-Lescure A, Ruiz Galiana J, Sureda AM, Tejerina-Picado F, Trilla A, Zapatero A, Palomo E, San-Miguel J. Bouza E, et al. Among authors: trilla a. Rev Esp Quimioter. 2023 Feb;36(1):1-25. doi: 10.37201/req/087.2022. Epub 2022 Nov 2. Rev Esp Quimioter. 2023. PMID: 36322133 Free PMC article. Review.
Meningococcal meningitis in Spain in the Horizon 2030: A position paper.
Moraga-Llop F, Andradas E, Blesa-Baviera LC, Cantón R, González Del Castillo J, Martinón-Torres F, Moya E, Trilla A, Vazquez J, Villena RJ, Ruiz-Galiana J, De Lucas Ramos P, García-Botella A, García-Lledó A, Hernández-Sampelayo T, Gómez-Pavón J, Martín-Delgado MC, Martín Sánchez FJ, Martínez-Sellés M, Molero García JM, Moreno Guillén S, Rodríguez-Artalejo FJ, Bouza E. Moraga-Llop F, et al. Among authors: trilla a. Rev Esp Quimioter. 2024 Aug;37(4):285-298. doi: 10.37201/req/023.2024. Epub 2024 Mar 22. Rev Esp Quimioter. 2024. PMID: 38515374 Free PMC article. Review.
Humoral and Cellular Immune Responses After a 3-dose Course of mRNA-1273 COVID-19 Vaccine in Kidney Transplant Recipients: A Prospective Cohort Study.
Cucchiari D, Egri N, Rodriguez-Espinosa D, Montagud-Marrahi E, Casals-Urquiza J, Del Risco-Zevallos J, Bodro M, Ventura-Aguiar P, Cofan F, Cacho J, Molina-Andujar A, Rovira J, Banon-Maneus E, José Ramirez-Bajo M, Pérez-Olmos A, Garcia-Pascual M, Pascal M, Vilella A, Trilla A, Palou E, Revuelta I, Juan M, Campistol JM, Oppenheimer F, Moreno A, Miró JM, Bayés B, Diekmann F. Cucchiari D, et al. Among authors: trilla a. Transplant Direct. 2022 Oct 7;8(11):e1389. doi: 10.1097/TXD.0000000000001389. eCollection 2022 Nov. Transplant Direct. 2022. PMID: 36245998 Free PMC article.
Tolerability and Reactogenicity Profile of mRNA SARS-Cov-2 Vaccines from a Mass Vaccination Campaign in a Tertiary Hospital: Between-Vaccine and Between-Population Prospective Observational Study (VigilVacCOVID Study).
Sáez-Peñataro J, Torres F, Bartra J, Bascuas J, Vilella A, Tortajada M, Quesada S, González E, López-Suñé E, Castells A, Serrano S, Camacho C, Trilla A, Calvo G; VigilVacCOVID Group. Sáez-Peñataro J, et al. Among authors: trilla a. BioDrugs. 2022 Jul;36(4):509-520. doi: 10.1007/s40259-022-00543-9. Epub 2022 Jun 28. BioDrugs. 2022. PMID: 35764768 Free PMC article.
247 results